Surgery improves kidney cancer survival: study
NEW YORK (Reuters Health) - Surgical removal of the kidney — a procedure known as nephrectomy — improves survival in patients with locally advanced renal cell carcinoma, the most common form of kidney cancer.
Dr. Pierre I. Karakiewicz from University of Montreal and colleagues determined survival rates for 43,143 patients treated with nephrectomy for advanced renal cell carcinoma that had not spread to other sites and a group of similar patients that did not have the surgery.
Death due to cancer was 5.8-fold higher for nonsurgical therapy than for nephrectomy, the team reports.
In a second analysis, where a subset of patients treated without surgery were matched with up to four surgically treated patients, there was still a 5.1-fold higher rate of cancer-specific mortality (death) in the nonsurgical group than in the nephrectomy group.
Overall, 5- and 10-year estimates of cancer-specific survival were 68.6 percent and 57.5 percent, respectively, for the nephrectomy group, compared with just 14.5 percent and 10.6 percent, respectively, for the nonsurgical therapy group.
This study, the investigators conclude, show that nonsurgical therapy is associated with a 44 percent to 57 percent worse survival than nephrectomy.
“Based on these findings, nephrectomy should be considered as the treatment of choice for patients with locally advanced renal cell carcinoma,” they conclude.
SOURCE: BJU (British Journal of Urology) International, December 2008.
--------------------------------------------------------------------------------------------Related Posts:
NEW YORK (Reuters Health) - Surgery to remove the esophagus is not being used as often as it should be for some cases of early-stage cancer of the esophagus. That’s the conclusion of Dr. E. Carter Paulson and colleagues, from the Hospital of the University of Pennsylvania in Philadelphia, who assessed the treatment of 2,386 patients
Full Post: Surgery underused for esophagus cancer: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - The risk of a rare form of liver cancer called intrahepatic cholangiocarcinoma, which occurs in the bile ducts of the liver, is significantly elevated in individuals who are infected with hepatitis C virus (HCV), according to a large “case-control” study of US veterans. HCV-infected individuals are also at increased risk for
Full Post: Hepatitis C ups liver cancer risk, study confirms
--------------------------------------------------------------------------------------------
Basal cell carcinoma is a skin cancer that grows in areas which receives a lot of sun rays. It is the least risky type of skin cancer as compared to the other types. If it is detected early, it can be cured. This skin cancer doesn’t reach to other parts of the body, but may
Full Post: Basal Cell Carcinoma In Men
--------------------------------------------------------------------------------------------
LONDON (Reuters) - Scientists have found two new genetic variations that appear to increase the risk of the most common skin cancer among people of European descent. The variations play no role in skin color but people with both of them are nearly three times more likely to develop basal cell carcinoma compared with people without
Full Post: Two more genes linked to common skin cancer
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - Adding radiation therapy to standard drug treatment can cut in half the death rate from advanced prostate cancer and should become the standard of care globally, Swedish researchers reported on Monday. Their study of more than 800 prostate cancer patients showed that nearly 24 percent of men who got only standard drugs had
Full Post: Radiation therapy cuts prostate cancer death: study